IL6 and neoplasm: R848 delivered by complement C3-targeted liposomes triggered various signal cascades to increase the expression of cytokines and factors (such as TNF-α, IL-1β, IL-6 and IL-12), leading to the delay of tumor growth in 4T1 tumor-bearing mice [114].